Heat Biologics, Inc. (HTBX) financial statements (2021 and earlier)

Company profile

Business Address 627 DAVIS DRIVE
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:15281081214
Cash and cash equivalents92210854
Short-term investments66  711
Other undisclosed cash, cash equivalents, and short-term investments (0)    
Receivables0000  
Prepaid expense000   
Other current assets000   
Other undisclosed current assets012011
Total current assets:15291281215
Noncurrent Assets
Property, plant and equipment110000
Long-term investments and receivables     0
Due from related parties     0
Deposits noncurrent assets     0
Restricted cash and investments     0
Deferred costs     0
Other noncurrent assets1088000
Other undisclosed noncurrent assets     (0)
Total noncurrent assets:1198111
TOTAL ASSETS:26382091316
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities333243
Accounts payable211021
Accrued liabilities222121
Employee-related liabilities     1
Deferred revenue3
Debt0   30
Due to related parties     0
Business combination, contingent consideration, liability21    
Deferred revenue and credits7   
Other undisclosed current liabilities 1   (1)
Total current liabilities:8510273
Noncurrent Liabilities
Long-term debt and lease obligation2   42
Long-term debt, excluding current maturities    42
Finance lease, liability0
Operating lease, liability2
Liabilities, other than long-term debt32400 
Deferred revenue0
Deferred tax liabilities, net01   
Deferred income tax liabilities0
Other liabilities 0000 
Business combination, contingent consideration, liability223   
Other undisclosed noncurrent liabilities 0    
Total noncurrent liabilities:434042
Total liabilities:138142115
Stockholders' equity
Stockholders' equity attributable to parent, including:143079412
Common stock000000
Additional paid in capital11811576664936
Accumulated other comprehensive loss(0)(0)(0)(0)(0) 
Accumulated deficit(105)(85)(69)(57)(44) 
Other undisclosed stockholders' equity attributable to parent     (24)
Stockholders' equity attributable to noncontrolling interest(0)(0)(2)(2)(2)(1)
Total stockholders' equity:133067211
TOTAL LIABILITIES AND EQUITY:26382091316

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net 0  
Gross profit:3620  
Operating expenses(24)(24)(15)(13)(21)(12)
Operating loss:(21)(18)(13)(13)(21)(12)
Nonoperating income (expense)0000(0)(0)
Investment income, nonoperating    0 
Other nonoperating income (expense)(0)0010(0)
Interest and debt expense(0)  (1)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(20)(18)(13)(14)(21)(12)
Other undisclosed income from continuing operations before income taxes0     
Loss from continuing operations before income taxes:(20)(18)(13)(14)(21)(12)
Income tax expense (benefit)(0)11   
Loss before gain (loss) on sale of properties:(20)(17)(12)(14)(21)(12)
Other undisclosed net income   100
Net loss:(20)(17)(12)(13)(21)(12)
Net income attributable to noncontrolling interest011010
Net loss available to common stockholders, diluted:(20)(16)(12)(13)(20)(12)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(20)(17)(12)(13)(21)(12)
Other comprehensive income (loss)00(0)0(0) 
Comprehensive loss:(20)(16)(13)(13)(21)(12)
Comprehensive income, net of tax, attributable to noncontrolling interest011010
Comprehensive loss, net of tax, attributable to parent:(20)(16)(12)(13)(20)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: